|
|
||||||||
1 Department of Pharmacology, 2 Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA 92697-4625

Neuropeptide S (NPS) is a newly identified transmitter that modulates arousal and fear responses. NPS activates an orphan G proteincoupled receptor that is expressed throughout the central nervous system, including brain centers that regulate sleep/wakefulness and anxiety. In contrast, the NPS precursor mRNA is found only in a few discrete nuclei in the brainstem as well as in a few scattered cells in the hypothalamus and amygdala. The most prominent expression of NPS precursor is found in a previously uncharacterized cluster of neurons in the pontine area, located between the noradrenergic locus ceruleus and Barringtons nucleus. Central administration of NPS induces long-lasting arousal and suppresses all stages of sleep. In addition, NPS produces an anxiolytic profile in a variety of behavioral models. The unique pharmacological spectrum of NPS makes it an interesting target for pharmaceutical development. It also enhances our understanding of the neurobiological mechanisms of sleep/wakefulness regulation and the neuronal processing of stress.
This article has been cited by other articles:
![]() |
L. S. Stone and D. C. Molliver In Search of Analgesia: Emerging Poles of GPCRs in Pain Mol. Interv., October 1, 2009; 9(5): 234 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Paneda, S. Huitron-Resendiz, L. M. Frago, J. A. Chowen, R. Picetti, L. d. Lecea, and A. J. Roberts Neuropeptide S Reinstates Cocaine-Seeking Behavior and Increases Locomotor Activity through Corticotropin-Releasing Factor Receptor 1 in Mice J. Neurosci., April 1, 2009; 29(13): 4155 - 4161. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |